• (Add Comment)

Cerebrolysin 1 ml 10 ampoules

320£

View analogs
Out of stock
  • Alzheimer’s disease
  • Dementia syndrome of various origins.
  • Chronic cerebrovascular insufficiency.
  • Ischemic stroke.
  • Traumatic injuries of the brain and spinal cord.
  • Mental developmental delay in children.
  • Attention disorders in children.
  • Endogenous depression resistant to antidepressants (as part of combination therapy).

Form of Release: Ampoules

Product Categories: Brain and cerebral circulationNootropics

Cerebrolysin 1 ml 10 ampoules

Composition:

Cerebrolysin concentrate (peptide complex) — 215.2 mg (per 1 ml solution).

Product Description:

Cerebrolysin is a nootropic peptide preparation containing low‑molecular biologically active neuropeptides.
These peptides cross the blood–brain barrier and act directly on nerve cells.
The drug has organ‑specific multimodal effects on the brain: it regulates metabolism, protects neurons, provides neurotrophic activity, and improves cognitive functions.

Indications for use:

  • Alzheimer’s disease
  • Dementia syndrome of various origins.
  • Chronic cerebrovascular insufficiency.
  • Ischemic stroke.
  • Traumatic injuries of the brain and spinal cord.
  • Mental developmental delay in children.
  • Attention disorders in children.
  • Endogenous depression resistant to antidepressants (as part of combination therapy).

Method of administration and dosage:

The drug is administered parenterally.
Dosage and duration depend on the nature and severity of the disease, as well as the patient’s age.
Intramuscular injections — up to 5 ml;
Intravenous injections — up to 10 ml;
Intravenous infusions — 10 to 50 ml (slowly, after dilution with standard infusion solutions, duration 15–60 minutes). 
Recommended course: daily injections for 10–20 days.

Contraindications:

  • Severe renal insufficiency
  • Status epilepticus
  • Hypersensitivity to the drug

Precautions:

Rapid administration may cause sensations of heat, sweating, dizziness. 
The drug should be administered slowly.
Clinical studies have shown no effect on the ability to drive vehicles or operate machinery.

Side effects:

  • Immune system: very rare — allergic reactions.
  • Psychiatric: rare — agitation, aggressive behavior, confusion, insomnia.
  • Nervous system: rare — dizziness; very rare — epilepsy, seizures.
  • Cardiovascular system: very rare — tachycardia, arrhythmia.
  • Digestive system: very rare — dyspepsia, diarrhea, constipation, nausea, vomiting; rare — loss of appetite.
  • Skin and subcutaneous tissue: very rare — skin reactions; rare — itching, sweating.
  • General reactions: very rare — redness, itching at the injection site.

Pregnancy and lactation:

Use is possible only under medical supervision, considering benefit versus potential risk.

Storage conditions:

Store at temperatures not exceeding 25 °C, in a dark place.

Packaging:

Carton box contains 10 ampoules of 1 ml and an instruction leaflet.

No comments yet. Be the first to write one.

Leave a Comment

Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.

I'm not a robot